InsidersTradesSigma
우리바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 우리바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 우리바이오 has recorded 5 insider filings. Market capitalisation: €44bn. The latest transaction was reported on 30 June 2026 (Other). Among the most active insiders: 우리바이오. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,033 of 28,134 companies
40.2
score / 100
Value63
Quality18
FCF yld28%
Earn yld-21%
EV/EBITDA6.3x
ROE·
Gross mgn9.1%
Net mgn-0.9%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
About 우리바이오
우리바이오 is a healthcare and pharmaceutical company listed on the XKRX. It focuses on developing innovative biopharmaceutical solutions.